RxDoctor Payments Data

Caitlan Clancy, DPM

Podiatrist · Atlantis, FLNPI 1013405935

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,299 of the $9,999 with a category attached, or 73.0%. 20 manufacturers reported payments, led by Stryker at 36.0% of the total. Reporting peaked in 2022 at $3,196 and has fallen 63.7% since, to $1,160 in 2025. Among podiatrist clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,999in general payments, 2019–2025

Across 119 payments — averaging $84.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$4K
  • Arthrex$2K
  • Treace Medical Concepts, Inc.$757
  • Integra Lifesciences Corporation$410
  • Flower Orthopedics Coporation$386
  • Biocomposites Inc$334
  • plus $2K from 14 others

What the payments were for

  • Travel & lodging$1,34413%
  • Food & beverage$7,29973%
  • Education$1,35614%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,999 in reported general payments places this provider in the 90th percentile of 588 podiatrist providers in Florida.

See all podiatrist providers in Florida

Medicare billing

Part B allowed, 2024
$92,206
Medicare patients
203
Services billed
945

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox19$433
Gabapentin51$211
Cephalexin18$210
Ketoconazole12$183
Meloxicam58$128
Methylprednisolone16$120
Terbinafine Hcl12$83

Paid to pharmacies, not to this prescriber.

Other podiatrist in Atlantis

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →